Heart Failure

Incident atrial fibrillation in a cohort of patients with hypertrophic cardiomyopathy, or HCM, was associated with elevated risk for cardiac death, according to research published in EClinicalMedicine.

Beta-blockers were not associated with depression and other psychiatric adverse events, although they may have a relationship with sleep disorders, according to a meta-analysis.

In contrast to their prevalence in the overall disease population, Black individuals were considerably underrepresented in trials that affirmed the FDA’s approval of 24 CVD treatments, researchers reported.

Patients presenting with STEMI who do not have standard modifiable CV risk factors are at elevated risk for all-cause mortality, according to results published in The Lancet.

The American Heart Association and Association of Black Cardiologists launched a joint data challenge to better understand the effects of social and structural determinants of health in HF.

The use of mineralocorticoid receptor antagonists did not influence the ability of empagliflozin to reduce adverse HF and renal outcomes, according to data from EMPEROR-Reduced published in the Journal of the American College of Cardiology.

Amyloidosis is a disease in which specific precursor proteins misfold into beta-pleated sheets. Misfolded proteins adhere to form oligomers resulting in insoluble amyloid fibrils that deposit into tissue.

Female sex was independently associated with diastolic dysfunction and worse clinical outcomes in a cohort of older patients with HF with preserved ejection fraction, researchers reported.

Subclinical impairments in left ventricular systolic function were associated with risk for future incident HF among older adults, according to research published in JAMA Cardiology.

Patients with mild HF on cardiac resynchronization therapy had lower risk for mortality if they improved or stabilized on CRT compared with if they worsened, researchers reported.